Psychiatry & Neurology, Neuromuscular Medicine · Rancho Mirage, CA
NPI
1265558753
Since 2007
Specialty
Psychiatry & Neurology, Neuromuscular Medicine
Code 2084N0008X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
72780 Country Club Dr Ste 205
Rancho Mirage, CA, 92270
Phone (760) 834-3540
Groups this clinician bills Medicare through
Medicare paid, 2024
$217K
3,017 services
Medicare patients, 2024
850
Average age 75
Drug cost, 2024
$19.0M
2,207 prescriptions
Company payments, 2025
$215K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samir P Macwan was code 95886 (electrical nerve conductivity), 672 times for 401 patients. In total Samir P Macwan billed 3,017 services in 39 codes, and Medicare paid $217K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95886 Electrical Nerve Conductivity | Office | 672 | 401 | $40.36 | $27K |
| 99214 Office E&M - Established | Office | 377 | 259 | $81.67 | $31K |
| 99204 Office E&M - New | Office | 310 | 310 | $105.96 | $33K |
| 64615 Musculoskeletal | Office | 222 | 78 | $90.68 | $20K |
| 64616 Musculoskeletal | Office | 178 | 63 | $106.58 | $19K |
| 95911 Electrical Nerve Conductivity | Office | 158 | 147 | $111.67 | $18K |
| 95909 Electrical Nerve Conductivity | Office | 154 | 153 | $72.80 | $11K |
| 95874 Musculoskeletal | Office | 140 | 57 | $16.82 | $2,354 |
| 64646 Musculoskeletal | Office | 115 | 49 | $57.72 | $6,638 |
| 99215 Office E&M - Established | Office | 87 | 71 | $114.91 | $9,998 |
| 99213 Office E&M - Established | Office | 71 | 69 | $44.56 | $3,164 |
| 99205 Office E&M - New | Office | 44 | 44 | $139.38 | $6,133 |
| 95912 Electrical Nerve Conductivity | Office | 42 | 42 | $121.22 | $5,091 |
| 95913 Electrical Nerve Conductivity | Office | 38 | 38 | $153.76 | $5,843 |
| 95910 Electrical Nerve Conductivity | Office | 35 | 35 | $108.82 | $3,809 |
By year: 2022 $266K for 3,986 services; 2023 $246K for 4,375 services; 2024 $217K for 3,017 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samir P Macwan prescribed most often to Medicare patients was Gamunex-C (Immune Globul G/Gly/Iga Avg 46), with 325 prescriptions and refills. In total Samir P Macwan wrote 2,207 Medicare prescriptions that cost $19.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 325 | 325 | 23 | $2.6M |
| Panzyga Immun Glob G(Igg)-Ifas/Glycine | 252 | 252 | 17 | $4.0M |
| Prednisone Generic | 162 | 401 | 44 | $1,377 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 107 | 107 | 13 | $1.7M |
| Sodium Chloride 0.9 % Sodium Chloride | 93 | 93 | 12 | $664 |
| Pyridostigmine Bromide Generic | 90 | 168 | 30 | $6,245 |
| Gammaked Immune Globul G/Gly/Iga Avg 46 | 85 | 85 | Under 11 | $1.1M |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 76 | 76 | Under 11 | $1.0M |
| Gabapentin Generic | 75 | 160 | 22 | $1,312 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 60 | 60 | Under 11 | $754K |
| Mycophenolate Mofetil Generic | 60 | 154 | 13 | $11K |
| Soliris Eculizumab | 54 | 54 | Under 11 | $1.4M |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 52 | 52 | Under 11 | $941K |
| Vyvgart Hytrulo Efgartigimod-Hyaluronidas-Qvfc | 42 | 48 | Under 11 | $2.1M |
| Epinephrine Generic | 41 | 41 | 39 | $12K |
Brand drugs: 1,376 claims; generic drugs: 831 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samir P Macwan $215K ($204K in general payments such as food, travel and fees and $11K for research) from 20 companies. The largest payer was Argenx US, Inc. with $71K.
| Company | Payments | Amount |
|---|---|---|
| Argenx US, Inc. ARGX | 55 | $71K |
| Alexion Pharmaceuticals, Inc. AZN | 37 | $50K |
| UCB, Inc. UCB.BR | 71 | $46K |
| Abbvie Inc. ABBV | 51 | $21K |
| Grifols USA, LLC | 14 | $14K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 26 | $4,843 |
| Amgen Inc. AMGN | 9 | $3,737 |
| Grifols Shared Services North America, Inc. | 1 | $1,819 |
| Catalyst Pharmaceuticals, Inc. CPRX | 4 | $1,397 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 18 | $378 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.